Fund shareholders of Oculis Holding AG
ISIN CH1242303498 · Switzerland · LEI 5067005370C2KK324336
- Fund shareholders
- 20
- Of which ETFs
- 5 15 other funds
- Value held
- 12.8M $
- Sold short
- 0.7 % by 1 fund, as of Aug 20, 2026
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 314,736 | 3.6M $ | 0.31 % | as of Jul 31, 2026 ↗ |
| Global Macro Absolute Return Advantage Portfolio Global Macro Absolute Return Advantage Portfolio | 109,990 | 1.2M $ | 0.02 % | as of Jul 31, 2026 ↗ |
| VANGUARD INTERNATIONAL EXPLORER FUND VANGUARD WHITEHALL FUNDS | 105,659 | 1.2M $ | 0.08 % | as of Jul 31, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 69,223 | 782.9K $ | 0.12 % | as of Jul 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 58,929 | 1.4M $ | 0.84 % | as of May 31, 2026 ↗ |
| HARTFORD SMALL COMPANY HLS FUND HARTFORD SERIES FUND INC | 45,414 | 629.9K $ | 0.13 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 36,061 | 828.7K $ | 0.00 % | as of May 31, 2026 ↗ |
| Nationwide International Small Cap Fund Nationwide Mutual Funds | 31,240 | 353.3K $ | 0.12 % | as of Jul 31, 2026 ↗ |
| Small Cap Stock Trust John Hancock Variable Insurance Trust | 28,218 | 391.4K $ | 0.13 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 28,027 | 317K $ | 0.68 % | as of Jul 31, 2026 ↗ |
| Global Macro Portfolio Global Macro Portfolio | 26,940 | 299.6K $ | 0.01 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 24,995 | 574.4K $ | 0.01 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 23,577 | 327K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| MassMutual Small Cap Growth Equity Fund MASSMUTUAL SELECT FUNDS | 19,191 | 266.2K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| International Opportunities Fund VALIC Co I | 14,922 | 338.8K $ | 0.11 % | as of May 31, 2026 ↗ |
| GlacierShares Nasdaq Iceland ETF Listed Funds Trust | 8,013 | 111.1K $ | 7.95 % | as of Jun 30, 2026 ↗ |
| MML VIP Wellington Small Cap Growth Equity Fund MML SERIES INVESTMENT FUND | 7,623 | 105.7K $ | 0.07 % | as of Jun 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 6,075 | 84.3K $ | 0.02 % | as of Jun 30, 2026 ↗ |
| Virtus AlphaSimplex Global Alternatives Fund Virtus Alternative Solutions Trust | 872 | 12.1K $ | 0.02 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 307 | 3.5K $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| GlacierShares Nasdaq Iceland ETF Listed Funds Trust | 7.95 % | as of Jun 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.84 % | as of May 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.68 % | as of Jul 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.31 % | as of Jul 31, 2026 ↗ |
| HARTFORD SMALL COMPANY HLS FUND HARTFORD SERIES FUND INC | 0.13 % | as of Jun 30, 2026 ↗ |
| Small Cap Stock Trust John Hancock Variable Insurance Trust | 0.13 % | as of Jun 30, 2026 ↗ |
| Nationwide International Small Cap Fund Nationwide Mutual Funds | 0.12 % | as of Jul 31, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 0.12 % | as of Jul 31, 2026 ↗ |
| International Opportunities Fund VALIC Co I | 0.11 % | as of May 31, 2026 ↗ |
| VANGUARD INTERNATIONAL EXPLORER FUND VANGUARD WHITEHALL FUNDS | 0.08 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 20 | -4 | 960,012 | -21.6 % |
| 2026Q2 | 24 | +11 | 1,223,954 | +84.6 % |
| 2026Q1 | 13 | +2 | 663,025 | +54.5 % |
| 2025Q4 | 11 | +4 | 429,020 | +339.4 % |
| 2025Q3 | 7 | +3 | 97,646 | +124.7 % |
| 2025Q2 | 4 | +1 | 43,450 | +36.2 % |
| 2025Q1 | 3 | 0 | 31,900 | +0.2 % |
| 2024Q4 | 3 | +1 | 31,842 | +35.0 % |
| 2024Q3 | 2 | +1 | 23,578 | +87.7 % |
| 2024Q2 | 1 | 0 | 12,559 | +128.2 % |
| 2024Q1 | 1 | 0 | 5,503 | 0.0 % |
| 2023Q4 | 1 | 5,503 |
Short sellers of Oculis Holding AG
Regulators publish the open short positions in this company. Titelia read them from quivad on Aug 20, 2026: today's figure
| Seller | Position | Disclosed on |
|---|---|---|
| D. E. Shaw & Co. L.P. | 0.7 % | Jul 24, 2026 |
Cite this page
Titelia. "Fund shareholders of Oculis Holding AG". https://titelia.com/en/stocks/oculis-holding-ag-CH1242303498